Atlas Trials

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Clinical trial NCT00331487 · COMPLETED

Trial details

NCT number
NCT00331487
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2000-09-01
Primary completion
2004-03-01
Enrollment
719

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.